C. Wilson

A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20.

Y. M. van der Linden, P. Hoskin, J. Pater, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial.

P. Richardson, K. Pritchard, M. Pollak, 2006, Journal of Clinical Oncology.

Serum 1-OH vitamin D (D) and prognosis of postmenopausal breast cancer (BC) patients: NCIC-CTG MA14 trial.

K. Pritchard, M. Pollak, L. Shepherd, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results

R. Eastell, C. Twelves, I. Macpherson, 2022, Journal of bone oncology.

Bevacizumab (BV) maintenance therapy significantly delays disease progression (PD) or death compared with placebo (PL) in the AVADO trial (BV + docetaxel [D] vs D + PL in 1st-line HER2-negative locally recurrent [LR] or metastatic breast cancer [mBC]).

R. Greil, S. Barni, D. Miles, 2009 .